The β1 adrenoceptor (AR) blocker metoprolol normalises βAR cascade and caveolar protein expression and restores β1AR responsiveness in failing right ventricular myocytes. [PDF]
Norman R +5 more
europepmc +1 more source
The prognostic impact of beta blockers in ischemic heart failure: time for a paradigm shift? [PDF]
Castiello DS +5 more
europepmc +1 more source
Beta-Blockers for Vasovagal Syncope in Aging Subjects: A Randomized Controlled Trial and Individual Patient Data Meta-Analysis of Clinical Trials. [PDF]
Sepehrvand N +10 more
europepmc +1 more source
Catecholaminergic neurons boost fibroblast osteogenic activity in keloid. [PDF]
Lou F +10 more
europepmc +1 more source
Amiodarone-metoprolol co-administration enhances heart rate variability and suppresses inflammatory cytokines in tachyarrhythmia patients. [PDF]
Han X, Xin Z.
europepmc +1 more source
Profound Synergistic Bradycardia: Pharmacokinetic Consequences of Paxlovid-Mediated CYP3A4 and CYP2D6 Inhibition on Ranolazine, Diltiazem, and Metoprolol. [PDF]
Bactawar SB, Gaibor C, Abdul-Waheed M.
europepmc +1 more source
Metoprolol-spironolactone combination for coronary heart disease with concurrent heart failure: impact on cardiac function. [PDF]
Zhao S, Zhang J, Zhao Y.
europepmc +1 more source
CYP2D6 as an Emerging Endogenous Oxidative Stress Modulator in Cardiovascular Disease: Genetic, Pharmacological, and Redox Perspectives. [PDF]
Yang CW, Chen WH, Lee TS.
europepmc +1 more source
The ODYSSEY-HCM and MAPLE-HCM studies: the role of cardiac myosin inhibitors in hypertrophic cardiomyopathy (obstructive and non-obstructive). [PDF]
Biagini E, Schiavo MA.
europepmc +1 more source
COVID-19 Myocarditis Presenting With New-Onset Heart Failure With Mildly Reduced Ejection Fraction and Rare Ventricular Quadrigeminy. [PDF]
Costa A +4 more
europepmc +1 more source

